Patents by Inventor Resverlogix Corp.

Resverlogix Corp. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS FOR SUBSTITUTED QUINAZOLINONES
    Publication number: 20130108672
    Abstract: The present disclosure relates to novel solid pharmaceutical formulations and process for their preparation. The present disclosure also provides, in part, methods of using the pharmaceutical formulations for regulating the expression of apolipoprotein A-I (ApoA-I), and their use for the treatment and prevention of cardiovascular disease and related disease states, including cholesterol- or lipid-related disorders, such as, for example, atherosclerosis.
    Type: Application
    Filed: October 31, 2012
    Publication date: May 2, 2013
    Applicant: Resverlogix Corp.
    Inventor: Resverlogix Corp.